Literature DB >> 21603994

Prospective study on the dose distribution to the acoustic structures during postoperative 3D conformal radiotherapy for parotid tumors: dosimetric and audiometric aspects.

Barbara A Jereczek-Fossa1, Elena Rondi, Andrzej Zarowski, Alberto D'Onofrio, Daniela Alterio, Mario Ciocca, Livia Corinna Bianchi, Marco Krengli, Luca Calabrese, Mohssen Ansarin, Gioacchino Giugliano, Roberto Orecchia.   

Abstract

BACKGROUND AND
PURPOSE: To analyze dose distribution in the hearing organ and to evaluate the dose effect on the hearing thresholds in patients treated with post-parotidectomy 3-dimensional conformal radiotherapy (3D-CRT). METHODS AND MATERIALS: A total of 17 patients received post-parotidectomy 3D-CRT (median dose: 63 Gy). The audiometric evaluation comprised pure tone audiometry and tympanometry performed before radiotherapy (RT) and 3, 6, and 24 months after RT. The ear structures were delineated on planning computer tomography scans. Mean and maximum doses were calculated and dose-volume histograms were plotted.
RESULTS: Before RT, the median baseline audiometric thresholds were normal. At 3 months post-RT, 3 patients were diagnosed as having middle ear underpressure and/or effusion that resolved completely by 6 months. During 2-year follow-up, none of the ears showed perceptive hearing loss at speech frequencies. The mean doses at ipsilateral external auditory canal, mastoids cells, tympanic case, Eustachian tube, semicircular canals, and cochlea were 44.8 Gy, 39.0 Gy, 30.9 Gy, 33.0 Gy, 19.6 Gy, and 19.2 Gy, respectively. The doses to the contralateral ear were negligible, except for the Eustachian tube (up to 28.2 Gy).
CONCLUSION: Post-parotidectomy 3D-CRT is associated with relatively low doses to the ear and the surrounding structures. Post-RT audiometry did not show any permanent (neither conductive nor perceptive) hearing impairment. Only in 3 patients were there signs of transient unilateral dysfunction of the Eustachian tube observed during the first few months after RT. Longer follow-up and larger patient series are warranted to confirm these preliminary findings.

Entities:  

Mesh:

Year:  2011        PMID: 21603994     DOI: 10.1007/s00066-011-2170-5

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  30 in total

1.  Patulous eustachian tube in long-term survivors of nasopharyngeal carcinoma.

Authors:  P W Cheng; Y H Young; P J Lou
Journal:  Ann Otol Rhinol Laryngol       Date:  1999-02       Impact factor: 1.547

2.  Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients.

Authors:  Charlie C Pan; Avraham Eisbruch; Julia S Lee; Rhonda M Snorrason; Randall K Ten Haken; Paul R Kileny
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-04-01       Impact factor: 7.038

3.  Sensori-neural hearing loss after radiotherapy for nasopharyngeal carcinoma: individualized risk estimation.

Authors:  Henriette B Honoré; Søren M Bentzen; Kitty Møller; Cai Grau
Journal:  Radiother Oncol       Date:  2002-10       Impact factor: 6.280

4.  High-grade acute organ toxicity as positive prognostic factor in primary radio(chemo)therapy for locally advanced, inoperable head and neck cancer.

Authors:  Hendrik Andreas Wolff; Jan Bosch; Klaus Jung; Tobias Overbeck; Steffen Hennies; Christoph Matthias; Clemens F Hess; Ralph M Roedel; Hans Christiansen
Journal:  Strahlenther Onkol       Date:  2010-04-26       Impact factor: 3.621

5.  Late radiation effects on hearing, vestibular function, and taste in brain tumor patients.

Authors:  Tom B Johannesen; Kjell Rasmussen; Finn Ø Winther; Ulf Halvorsen; Knut Lote
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-05-01       Impact factor: 7.038

6.  Brachial plexopathy after chemoradiotherapy for head and neck squamous cell carcinoma.

Authors:  Nele Platteaux; Piet Dirix; Robert Hermans; Sandra Nuyts
Journal:  Strahlenther Onkol       Date:  2010-08-30       Impact factor: 3.621

7.  A phase I/II study of altered fractionated IMRT alone for intermediate T-stage oropharyngeal carcinoma.

Authors:  G Brandon Gunn; Eugene J Endres; Brent Parker; Maria Pia Sormani; Giuseppe Sanguineti
Journal:  Strahlenther Onkol       Date:  2010-08-30       Impact factor: 3.621

8.  Radiation-induced hearing impairment in patients treated for malignant parotid tumor.

Authors:  W C Chen; C T Liao; H C Tsai; J Y Yeh; C C Wang; S G Tang; J H Hong
Journal:  Ann Otol Rhinol Laryngol       Date:  1999-12       Impact factor: 1.547

Review 9.  Radiotherapy-induced mandibular bone complications.

Authors:  Barbara A Jereczek-Fossa; Roberto Orecchia
Journal:  Cancer Treat Rev       Date:  2002-02       Impact factor: 12.111

10.  Committee on Hearing and Equilibrium guidelines for the evaluation of hearing preservation in acoustic neuroma (vestibular schwannoma). American Academy of Otolaryngology-Head and Neck Surgery Foundation, INC.

Authors: 
Journal:  Otolaryngol Head Neck Surg       Date:  1995-09       Impact factor: 3.497

View more
  4 in total

1.  Systematic Review of Normal Tissue Complication Models Relevant to Standard Fractionation Radiation Therapy of the Head and Neck Region Published After the QUANTEC Reports.

Authors:  N Patrik Brodin; Rafi Kabarriti; Madhur K Garg; Chandan Guha; Wolfgang A Tomé
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-09-29       Impact factor: 7.038

2.  Radiotherapy for vestibular schwannoma: Review of recent literature results.

Authors:  Giuseppina Apicella; Marina Paolini; Letizia Deantonio; Laura Masini; Marco Krengli
Journal:  Rep Pract Oncol Radiother       Date:  2016-02-28

3.  Proton versus conventional radiotherapy for pediatric salivary gland tumors: Acute toxicity and dosimetric characteristics.

Authors:  Stephen R Grant; David R Grosshans; Stephen D Bilton; John A Garcia; Mayank Amin; Mark S Chambers; Susan L McGovern; Mary F McAleer; William H Morrison; Winston W Huh; Michael E Kupferman; Anita Mahajan
Journal:  Radiother Oncol       Date:  2015-07-28       Impact factor: 6.280

4.  Melatonin reduces radiation damage in inner ear.

Authors:  Ting Chen; Yuling Luo; Qi Li; Chen Yang; Yixin Yuan; Jinhao Peng; Molu Ban; Yong Liang; Wei Zhang
Journal:  J Radiat Res       Date:  2021-03-10       Impact factor: 2.724

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.